Technology

Pipeline

Pipeline

Advancing new drug development and
natural functional ingredients through science-driven research.

Pharmaceuticals

  • IDC2101 : Central Hearing Loss Therapeutic

    Tech transfer goal 2030

  • IDN2410 : MASH Therapeutic

    Tech transfer goal 2031

  • IDN2501 : Arthritis Therapeutic

    Tech transfer goal 2031
Nutraceuticals

  • IFN1801 : Hearing Support

    2025 approval & Amazon launch

  • IFN2401 : Sleep Improvement

    Human trial in 2026

  • IFN2402 : Menopause Support

    2026 Amazon launch

  • IFN2501 : Blood Sugar & Fat Reduction

    Target launch 2027

  • IFN2502 : Liver Health Improvement

    Target launch 2027
Cosmetics

  • ICN2301 : Skin Soothing/Whitening/Anti-aging

    Clincal trial completed & raw materials on sale

  • ICN2501 : Menopause Skincare & Patch

    Preclinical and safety testing completed & 2026 Product launch